Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nano-X Imaging (NNOX) Other financing activities (2020 - 2025)

Historic Other financing activities for Nano-X Imaging (NNOX) over the last 6 years, with Q3 2025 value amounting to $571.9 million.

  • Nano-X Imaging's Other financing activities rose 927.06% to $571.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $571.9 million, marking a year-over-year increase of 927.06%. This contributed to the annual value of $562.7 million for FY2024, which is 907.19% up from last year.
  • Nano-X Imaging's Other financing activities amounted to $571.9 million in Q3 2025, which was up 927.06% from $565.1 million recorded in Q2 2025.
  • Nano-X Imaging's 5-year Other financing activities high stood at $456.8 billion for Q3 2022, and its period low was $322.3 million during Q1 2021.
  • Its 5-year average for Other financing activities is $50.9 billion, with a median of $516.6 million in 2023.
  • Its Other financing activities has fluctuated over the past 5 years, first surged by 13771286.79% in 2022, then tumbled by 9989.31% in 2023.
  • Quarter analysis of 5 years shows Nano-X Imaging's Other financing activities stood at $438.8 million in 2021, then grew by 8.92% to $478.0 million in 2022, then rose by 7.94% to $515.9 million in 2023, then rose by 9.07% to $562.7 million in 2024, then rose by 1.64% to $571.9 million in 2025.
  • Its last three reported values are $571.9 million in Q3 2025, $565.1 million for Q2 2025, and $564.0 million during Q1 2025.